Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1991;18(1):41–49.

Current Treatment of Dilated Cardiomyopathy

Edward K Massin 1
PMCID: PMC324959  PMID: 15227507

Abstract

Within the last decade, the treatment for patients with dilated cardiomyopathy has changed. Clinical management of these patients is aimed at controlling congestive heart failure, treating arrhythmias, preventing pulmonary and systemic emboli, and managing chest pain. The goals of treatment for patients with dilated cardiomyopathy are to make the patient feel better and live longer. To achieve this, we direct treatment to improving left ventricular function and cardiac output and controlling arrhythmias and thromboemboli. Basic treatment begins with inotropic therapy, preload reduction, and afterload reduction. For patients with symptomatic disease, we recommend diuretics, digoxin, and converting enzyme inhibitors for first-line therapy. Patients with arrhythmias may be treated by the addition of amiodarone, a pacemaker, or an automatic implantable cardioverter-defibrillator; and most such patients need to be anticoagulated. All patients need close follow-up for possible drug toxicity associated with their regimens. Heart transplantation can be considered for patients refractory to medical treatment. Although the incidence of dilated cardiomyopathy continues to increase, we are learning better ways to treat it. In the future, new drugs with fewer side effects should be available to treat, and perhaps impede, the development of dilated cardiomyopathy. (Texas Heart Institute Journal 1991;18:41-9)

Keywords: Cardiomyopathy, congestive/drug therapy

Full text

PDF
41

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Lutz J. R., Gilbert E. M., Sorensen S. G., Yanowitz F. G., Menlove R. L., Bartholomew M. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol. 1985 Feb 1;55(4):471–475. doi: 10.1016/0002-9149(85)90396-0. [DOI] [PubMed] [Google Scholar]
  2. Arnold S. B., Byrd R. C., Meister W., Melmon K., Cheitlin M. D., Bristow J. D., Parmley W. W., Chatterjee K. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med. 1980 Dec 18;303(25):1443–1448. doi: 10.1056/NEJM198012183032503. [DOI] [PubMed] [Google Scholar]
  3. BECKER B. J. P., CHATGIDAKIS C. B., VAN LINGEN B. Cardiovascular collagenosis with parietal endocardial thrombosis; a clinicopathologic study of forty cases. Circulation. 1953 Mar;7(3):345–356. doi: 10.1161/01.cir.7.3.345. [DOI] [PubMed] [Google Scholar]
  4. Chadda K., Goldstein S., Byington R., Curb J. D. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 1986 Mar;73(3):503–510. doi: 10.1161/01.cir.73.3.503. [DOI] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Findlay I. N., Wilson J. T. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. Br Heart J. 1987 May;57(5):436–445. doi: 10.1136/hrt.57.5.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  7. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Rector T. S. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 1988 Jul 11;62(2):25A–30A. doi: 10.1016/s0002-9149(88)80081-x. [DOI] [PubMed] [Google Scholar]
  9. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R. C., Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–683. doi: 10.1056/NEJM198903163201101. [DOI] [PubMed] [Google Scholar]
  10. Fisher J. D., Kim S. G., Mercando A. D. Electrical devices for treatment of arrhythmias. Am J Cardiol. 1988 Jan 15;61(2):45A–57A. doi: 10.1016/0002-9149(88)90739-4. [DOI] [PubMed] [Google Scholar]
  11. Fowles R. E., Bieber C. P., Stinson E. B. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation. 1979 Mar;59(3):483–491. doi: 10.1161/01.cir.59.3.483. [DOI] [PubMed] [Google Scholar]
  12. Fuster V., Gersh B. J., Giuliani E. R., Tajik A. J., Brandenburg R. O., Frye R. L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981 Mar;47(3):525–531. doi: 10.1016/0002-9149(81)90534-8. [DOI] [PubMed] [Google Scholar]
  13. GOLDBERG L. I., MCDONALD R. H., Jr, ZIMMERMAN A. M. SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE. N Engl J Med. 1963 Nov 14;269:1060–1064. doi: 10.1056/NEJM196311142692003. [DOI] [PubMed] [Google Scholar]
  14. Gage J., Rutman H., Lucido D., LeJemtel T. H. Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation. 1986 Aug;74(2):367–373. doi: 10.1161/01.cir.74.2.367. [DOI] [PubMed] [Google Scholar]
  15. Gottlieb S. S., Kukin M. L., Ahern D., Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989 Jun;13(7):1534–1539. doi: 10.1016/0735-1097(89)90344-6. [DOI] [PubMed] [Google Scholar]
  16. Hansteen V., Møinichen E., Lorentsen E., Andersen A., Strøm O., Søiland K., Dyrbekk D., Refsum A. M., Tromsdal A., Knudsen K. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed) 1982 Jan 16;284(6310):155–160. doi: 10.1136/bmj.284.6310.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hornung R. S., Hillis W. S. The acute haemodynamic effects of intravenous enalaprilic acid (MK422) in patients with left ventricular dysfunction. Br J Clin Pharmacol. 1987 Jan;23(1):29–33. doi: 10.1111/j.1365-2125.1987.tb03005.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jacobs B., Matsuda Y., Deodhar S., Shirey E. Cell-mediated cytotoxicity to cardiac cells of lymphocytes from patients with primary myocardial disease. Am J Clin Pathol. 1979 Jul;72(1):1–4. doi: 10.1093/ajcp/72.1.1. [DOI] [PubMed] [Google Scholar]
  19. Katz A. M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 1990 Jan 11;322(2):100–110. doi: 10.1056/NEJM199001113220206. [DOI] [PubMed] [Google Scholar]
  20. Kramer B., Topic N., Massie B. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure. Br J Clin Pharmacol. 1982;14 (Suppl 2):143S–151S. doi: 10.1111/j.1365-2125.1982.tb02071.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lee D. C., Johnson R. A., Bingham J. B., Leahy M., Dinsmore R. E., Goroll A. H., Newell J. B., Strauss H. W., Haber E. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med. 1982 Mar 25;306(12):699–705. doi: 10.1056/NEJM198203253061202. [DOI] [PubMed] [Google Scholar]
  22. Liang C., Tuttle R. R., Hood W. B., Jr, Gavras H. Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training. J Clin Invest. 1979 Aug;64(2):613–619. doi: 10.1172/JCI109501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Limas C. J., Goldenberg I. F., Limas C. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res. 1989 Jan;64(1):97–103. doi: 10.1161/01.res.64.1.97. [DOI] [PubMed] [Google Scholar]
  24. Limas C. J., Goldenberg I. F., Limas C. Effect of cardiac transplantation on anti-beta-receptor antibodies in idiopathic dilated cardiomyopathy. Am J Cardiol. 1989 May 1;63(15):1134–1137. doi: 10.1016/0002-9149(89)90094-5. [DOI] [PubMed] [Google Scholar]
  25. Luu M., Stevenson W. G., Stevenson L. W., Baron K., Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989 Dec;80(6):1675–1680. doi: 10.1161/01.cir.80.6.1675. [DOI] [PubMed] [Google Scholar]
  26. Massie B., Bourassa M., DiBianco R., Hess M., Konstam M., Likoff M., Packer M. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation. 1985 May;71(5):963–971. doi: 10.1161/01.cir.71.5.963. [DOI] [PubMed] [Google Scholar]
  27. Mulrow C. D., Mulrow J. P., Linn W. D., Aguilar C., Ramirez G. Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials. JAMA. 1988 Jun 17;259(23):3422–3426. [PubMed] [Google Scholar]
  28. Newman T. J., Maskin C. S., Dennick L. G., Meyer J. H., Hallows B. G., Cooper W. H. Effects of captopril on survival in patients with heart failure. Am J Med. 1988 Mar 11;84(3A):140–144. doi: 10.1016/0002-9343(88)90221-5. [DOI] [PubMed] [Google Scholar]
  29. O'Connell J. B. Immunosuppression for dilated cardiomyopathy. N Engl J Med. 1989 Oct 19;321(16):1119–1121. doi: 10.1056/NEJM198910193211609. [DOI] [PubMed] [Google Scholar]
  30. Rosenblum R., Tai A. R., Lawson D. Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease. J Pharmacol Exp Ther. 1972 Nov;183(2):256–263. [PubMed] [Google Scholar]
  31. Scholz H. Pharmacological actions of various inotropic agents. Eur Heart J. 1983 Jan;4 (Suppl A):161–172. doi: 10.1093/eurheartj/4.suppl_a.161. [DOI] [PubMed] [Google Scholar]
  32. Stratton J. R., Resnick A. D. Increased embolic risk in patients with left ventricular thrombi. Circulation. 1987 May;75(5):1004–1011. doi: 10.1161/01.cir.75.5.1004. [DOI] [PubMed] [Google Scholar]
  33. Unverferth D. V., Leier C. V., Magorien R. D., Croskery R., Svirbely J. R., Kolibash A. J., Dick M. R., Meacham J. A., Baba N. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study. J Pharmacol Exp Ther. 1980 Nov;215(2):527–532. [PubMed] [Google Scholar]
  34. Webster M. W., Fitzpatrick M. A., Nicholls M. G., Ikram H., Wells J. E. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol. 1985 Sep 15;56(8):566–569. doi: 10.1016/0002-9149(85)91186-5. [DOI] [PubMed] [Google Scholar]
  35. Winkle R. A., Mead R. H., Ruder M. A., Gaudiani V. A., Smith N. A., Buch W. S., Schmidt P., Shipman T. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1989 May;13(6):1353–1361. doi: 10.1016/0735-1097(89)90310-0. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES